HBAN vs. CBSH: Which Stock Is the Better Value Option?

The article identifies Huntington Bancshares (HBAN) as the superior value investment option compared to Commerce Bancshares (CBSH) within the Midwest banking sector. HBAN holds a Zacks Rank #2 (Buy) and a 'B' Value grade, outperforming CBSH's #3 (Hold) and 'C' grade. This assessment is supported by HBAN's more favorable valuation metrics, including a lower forward P/E (11.82 vs. 16.21), PEG ratio (1.28 vs. 2.96), and P/B ratio (1.35 vs. 2.53), suggesting a stronger value proposition for investors.

Analysis

A comparative analysis of two Midwest banking stocks positions Huntington Bancshares (HBAN) as the superior value option over Commerce Bancshares (CBSH). This conclusion is supported by the Zacks Rank system, which assigns HBAN a #2 (Buy) rating, indicating positive earnings estimate revisions and an improving analyst outlook, while CBSH holds a #3 (Hold) rating. On a quantitative basis, HBAN's valuation is more compelling across several key metrics. Its forward Price-to-Earnings (P/E) ratio is 11.82, significantly lower than CBSH's 16.21. Furthermore, HBAN's Price-to-Earnings-Growth (PEG) ratio of 1.28 suggests a more reasonable valuation relative to its growth prospects compared to CBSH's much higher 2.96. The disparity is also evident in the Price-to-Book (P/B) ratio, where HBAN's 1.35 is nearly half of CBSH's 2.53. These factors culminate in HBAN receiving a 'B' grade for Value in the Zacks Style Scores system, whereas CBSH receives a 'C'.

Key Decisions for Investors

• Value-oriented investors seeking exposure to the Midwest banking sector should consider Huntington Bancshares (HBAN) due to its superior valuation metrics and positive analyst estimate revisions compared to Commerce Bancshares (CBSH).
• Investors currently holding Commerce Bancshares (CBSH) may want to re-evaluate their position, given its higher relative valuation on P/E, PEG, and P/B ratios and its neutral 'Hold' rating.
• The primary driver of the favorable rating for HBAN is its positive earnings estimate revision trend, so investors should monitor forward guidance and analyst estimate changes for both companies as a key indicator for any potential shift in this thesis.